N
Naoki Harada
Researcher at Chugai Pharmaceutical Co.
Publications - 48
Citations - 1385
Naoki Harada is an academic researcher from Chugai Pharmaceutical Co.. The author has contributed to research in topics: Cancer & Trastuzumab. The author has an hindex of 17, co-authored 44 publications receiving 1265 citations.
Papers
More filters
Journal ArticleDOI
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.
Hiroyuki Takai,Kazuhito Naka,Yuki Okada,Miho Watanabe,Naoki Harada,Shin'ichi Saito,Carl W. Anderson,Ettore Appella,Makoto Nakanishi,Hiroshi Suzuki,Kazuo Nagashima,Hirofumi Sawa,Kyoji Ikeda,Noboru Motoyama +13 more
TL;DR: Chk2 plays a critical role in p53 function in response to IR by regulating its transcriptional activity as well as its stability, suggesting the existence of an ATM/ATR‐dependent but Chk2‐independent pathway for p53 stabilization.
Journal ArticleDOI
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Nobuya Ishii,Naoki Harada,Eric W. Joseph,Kazuhiro Ohara,Takaaki Miura,Hiroshi Sakamoto,Yutaka Matsuda,Yasushi Tomii,Yukako Tachibana-Kondo,Hitoshi Iikura,Toshihiro Aoki,Nobuo Shimma,Mikio Arisawa,Yoshihiro Sowa,Poulikos I. Poulikakos,Neal Rosen,Yuko Aoki,Toshiyuki Sakai +17 more
TL;DR: CH5126766 represents a new type of MEK inhibitor that causes MEK to become a dominant-negative inhibitor of RAF and that, in doing so, may have enhanced therapeutic activity in ERK-dependent tumors with mutant RAS.
Journal ArticleDOI
Human IgGFc Binding Protein (FcγBP) in Colonic Epithelial Cells Exhibits Mucin-like Structure
Naoki Harada,Shigeyuki Iijima,Kensuke Kobayashi,Kensuke Kobayashi,Takeshi Yoshida,William R. Brown,Toshifumi Hibi,Akihiro Oshima,Minoru Morikawa +8 more
TL;DR: Cloning a cDNA for human IgGFc binding protein (FcγBP) from human colonic epithelial cells reveals an mRNA and coding region of 17 and 16.2 kilobases, respectively, suggesting that Fcγ BP may play an important role in immune protection and inflammation in the intestines of primates.
Journal ArticleDOI
Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids
Kensuke Kobayashi,Haruhiko Ogata,Minoru Morikawa,Shigeyuki Iijima,Naoki Harada,Takeshi Yoshida,W R Brown,Nagamu Inoue,Yoshiki Hamada,Hiromasa Ishii,Mamoru Watanabe,T. Hibi +11 more
TL;DR: The immunohistochemical study revealed that mucin secreting cells in the colon, small intestine, gall bladder, cystic duct, choledochus, bronchus, submandibular gland, and cervix uteri contained FcγBP, and immunodotblot and immunoprecipitation analysis using IgG and monoclonal antibodies demonstrated that the fluids secreted by these cells were capable of binding IgG.
Patent
Coumarin derivative having antitumor activity
Hitoshi Iikura,Hyoudoh Ikumi,Toshihiro Aoki,Noriyuki Furuichi,Masayuki Matsushita,Watanabe Fumio,Ozawa Sawako,Sakaitani Masahiro,Ho Pil-Su,Tomii Yasushi,Takanashi Kenji,Naoki Harada +11 more
TL;DR: In this article, a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof (2) is presented. But the present invention does not provide a pharmaceutical composition containing the compound or salt as an active ingredient.